Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health.

Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Na

tera’s tests are validated by more than 250 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California.

06/07/2026

Cancer survivorship looks different for everyone. And we all know someone living it - they’re our colleagues, neighbors, friends, and family.

Talking about survivorship can be powerful, and this National Cancer Survivors Day, we’re honoring that. Several members of our Natera team are cancer survivors. Others have walked alongside loved ones as they navigate what it means to be a survivor. Those experiences shape the work we do every day. Each action helps raise awareness about early detection and survivorship support available to those in your circle.

If you or someone you know is navigating life after a cancer diagnosis, you're not alone.

Hear more from patients living life after diagnosis here: https://ow.ly/LKfq50Z8vGK

05/19/2026

Carrier screening can support earlier diagnosis and family preparedness for conditions such as cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and sickle cell anemia.

Carrier screening can be performed either before or during pregnancy.

You can find more info on Horizon™ genetic carrier screening right here: https://ow.ly/umUj50Z1MPN

05/18/2026

At 66, Jon was diagnosed with muscle-invasive bladder cancer and given a prognosis measured in months. After treatment and scans, Jon and his care team added Signatera™ personalized molecular residual disease (MRD) testing to his recurrence monitoring and it became his "beacon" through survivorship.

See Jon's full story and learn more about personalized MRD testing here: https://ow.ly/rQ4x50Z1gRh

04/25/2026

In honor of Awareness Month, we're sharing the story of Dr. James Duke, a retired orthopedic surgeon, who was diagnosed with squamous cell carcinoma. His story is a powerful reminder of the importance of community and that informed patients can shape their outcomes.

Learn more: https://ow.ly/V74y50YNsm3

04/21/2026

In support of National Infertility Awareness Week, we’re proud to partner with organizations like , which provides resources and support for people on their family planning journey. 🧡 Swipe through for infertility facts →

04/20/2026

🚀 This Lab Week, we are honored to celebrate our incredible laboratory teams who truly go "To Infinity and Beyond for Our Patients," ASCP's theme for this year.

Since our earliest days, our laboratory has served as the foundation for the insights on which individuals and families rely during their most pivotal moments. While our technology provides the platform, it is the care and expertise of our teams that transform every sample into a meaningful answer.

Thank you, lab teams, for your continued contributions to our mission!

04/08/2026

Have you registered for our Transplant Visiting Vignette?

Hal Harbuck, known to North Texas radio listeners as "Hal Jay," spent decades on air, earning him a spot in the Texas Hall of Fame. However, off- air Hal was quietly battling a serious heart condition. After years of cardiac events, including a heart attack and dangerous episodes of ventricular tachycardia, Hal's heart gradually weakened, and his doctors determined he needed a transplant🫀

During our Visiting Vignette, Hal will share his unique journey with a heart transplant while his wife Ann offers a caregiver's perspective of the journey. Our conversation will cover the uncertainty leading up to surgery, recovery, resilience, life beyond transplant, and leave time for a Q&A at the end🗣️

🔗You can register for the April 16th 4 PM EDT vignette at the link below:
https://ow.ly/NMT650YFgpu

Natera

04/07/2026

Dr. Lodhi shares how she can remain proactive for her potentially high risk transplant patients with routine use of the Prospera™ test.

03/14/2026

Join this upcoming webinar to learn how circulating tumor DNA (ctDNA) testing can help detect colorectal cancer recurrence earlier, monitor treatment response, and guide next steps in cancer care.

💙 Patients and caregivers are invited to submit questions in advance for presenter Dr. John Strickler, and he will answer as many as possible during the live Q&A.

📅Tuesday, March 17
🕗 5 PM PT | 8 PM ET
📍Register: https://ow.ly/IvbA50Ypc0Y

03/12/2026

Up to 1 in 5 people with chronic kidney disease (CKD) may have a genetic cause, and without genetic testing, those insights stay hidden. Identifying the underlying cause of CKD can help improve outcomes and quality of life. Learn more about how genetic testing can support kidney health: https://ow.ly/LT7O50YsQNR

Address

Belmont, CA

Website

http://natera.com/

Alerts

Be the first to know and let us send you an email when Natera posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Natera:

Shortcuts

Want your practice to be the top-listed Clinic in Belmont?